Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

Fig. 3

High expression level of BRCC3 in radioresistant NPC cell lines. a Western blot analysis of BRCC3 NPC cell lines; b Real-time PCR analysis of BRCC3 protein in the same cell lines as described in A. c Western blotting analysis of BRCC3 in CNE2 and CNE2R cells. d Realtime PCR analysis of BRCC3 in CNE2 and CNE2R cells. T test was used to compare the expression level, the asterisks indicate a significant (***p < 0.001) difference

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us